Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
Yildiz
Aysegul
A
Alkin
Tunc
T
Ozerdem
Aysegul
A
Sagduyu
Kemal
K
Demopulos
Christina M
CM
D000209:Acute-Phase Proteins / Q000032:analysis; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D003006:Clopenthixol / Q000009:adverse effects*; D018491:Dopamine Agonists / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology* / Q000628:therapy*; D013881:Thioridazine / Q000009:adverse effects*
D000209:Acute-Phase Proteins; D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D001971:Bromocriptine; D003006:Clopenthixol; D013881:Thioridazine